| CVLEX | RWMHX | CVLEX / RWMHX | |
| Total Expense Ratio | 1.00 | 0.41 | 244% |
| Annual Report Gross Expense Ratio | 2.71 | 0.41 | 661% |
| Fund Existence | 13 years | 10 years | - |
| Gain YTD | 2.687 | 2.169 | 124% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 28.3M | 208B | 0% |
| Annual Yield % from dividends | 1.19 | 1.38 | 86% |
| Returns for 1 year | 20.23 | 9.89 | 205% |
| Returns for 3 years | 20.80 | 31.32 | 66% |
| Returns for 5 years | 19.80 | 39.60 | 50% |
| Returns for 10 years | 56.25 | 101.22 | 56% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 41.49 | 1.67 | +4.19% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| KXI | 66.96 | 0.76 | +1.15% |
| iShares Global Consumer Staples ETF | |||
| VTV | 197.68 | 1.09 | +0.55% |
| Vanguard Value ETF | |||
| AFIF | 9.45 | N/A | -0.05% |
| Anfield Universal Fixed Income ETF | |||
| DMAX | 26.67 | -0.03 | -0.12% |
| iShares Large Cap Max Buffer Dec ETF | |||